Pioneer79
@gicoverage
How can we differentiate between LC patients with ongoing viral replication and those without, or those with lasting pathogenic fragments? It seems we need advanced immunological and other data to start categorizing patients accurately based on their underlying issues.
0 reply
0 recast
0 reaction